Informa
Antibody Engineering & Therapeutics US
2025年12月14-17日
米国、カリフォルニア州サンディエゴ、Marriott Marquis 対面式ライブイベント: 2025年12月14-17日

Pre-Conference Workshops (pm only) and Training Course (full day) - PT (Pacific Time, GMT-08:00)

Pre-Conference Workshops (pm only) and Training Course (full day) - PT (Pacific Time, GMT-08:00)
Optional Pre-Conference Training Course (9:00am-5:00pm) and Pre-Conference Workshops (1:00pm-5:00pm)
8:00am - 9:00am60 mins
Training Course: Introduction to Antibody Engineering
Training Course Registration
    9:00am - 5:00pm480 mins
    Training Course: Introduction to Antibody Engineering
    Introduction to Antibody Engineering
    • David Bramhill, PhD - Consultant, Bramhill Biological Consulting, LLC
    9:00am - 9:05am5 mins
    Early Career Scientist Session
    Early Career Scientist Session Welcome and Opening Remarks
    • Karen Silence, PhD - Head Preclinical Product Development, Argenx
    • Robert Chen, PhD - Antibody Engineer, Chai Discovery
    9:05am - 9:30am25 mins
    Early Career Scientist Session
    Fun Icebreaker with Antibody Quiz Game
    • Karen Silence, PhD - Head Preclinical Product Development, Argenx
    9:30am - 9:45am15 mins
    Early Career Scientist Session
    Early Career Scientist Presentation #1
      9:45am - 10:00am15 mins
      Early Career Scientist Session
      Early Career Scientist Presentation #2
        10:00am - 10:15am15 mins
        Early Career Scientist Session
        Early Career Scientist Presentation #3
          10:15am - 10:30am15 mins
          Early Career Scientist Session
          Early Career Scientist Presentation #4
            10:30am - 11:00am30 mins
            Early Career Scientist Session
            Career Path/Experiences Panel Discussion
            • Karen Silence, PhD - Head Preclinical Product Development, Argenx
            • Robert Chen, PhD - Antibody Engineer, Chai Discovery
            • Jenna Guthmiller, PhD - Assistant Professor, Department of Immunology, University of Colorado Anschutz Medical Campus
            • Stephen Beers, PhD - Professor of Immunology and Immunotherapy, University of Southampton
            • Jay Bhatt, PhD - Principal Scientist, Johnson & Johnson
            12:00pm - 12:15pm15 mins
            Workshop 1: Engineering Considerations for Candidate Selection and Developability
            Co-Chairs' Remarks: Engineering Considerations for Candidate Selection and Developability
            • Peyton Greenside, Ph.D. - Chief Scientific Officer and Co-founder, BigHat Biosciences
            • Javier Chaparro-Riggers, Ph.D. - Vice President, BioMedicine Design, Pfizer
            12:00pm - 12:15pm15 mins
            Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
            Co-Chairs' Remarks: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
            • Jonathan Sockolosky, PhD - Principal, Sockolosky & Associates
            • Jennifer Cochran, Ph.D. - Professor and Department Chair of Bioengineering, Stanford University
            12:15pm - 1:15pm60 mins
            Workshop 1: Engineering Considerations for Candidate Selection and Developability
            Optimizing Antibodies for Efficacy with Special Emphasis on Engineering and ADME
            • Javier Chaparro-Riggers, Ph.D. - Vice President, BioMedicine Design, Pfizer
            • Michael Zager, PhD - Associate Research Fellow, Pharmacokinetics, Dynamics, & Metabolism, Pfizer
            12:15pm - 12:45pm30 mins
            Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
            Creating Value in Biotech: Insights from an Investor Turned Operator and Back Again
            • Kelly Moynihan, PhD - VP, CSO Partner Team, Curie.Bio
            12:45pm - 1:15pm30 mins
            Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
            Lessons Learned during the Transition from Preclinical to Early Clinical Development/Clinical POC
            • Mohit Trikha, PhD - President & COO, Kivu Biosciences
            1:15pm - 1:45pm30 mins
            Workshop 1: Engineering Considerations for Candidate Selection and Developability
            Accelerating Biologics Discovery Through Early Developability Workflows and Tailored Strategies for Complex Formats
            • Laurence Fayadat-Dilman, Ph.D. - Executive Director, Discovery Biologics, Protein Sciences, Merck Research Laboratories
            1:15pm - 1:45pm30 mins
            Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
            Mixing and Matching: Partnering vs. Internal Development of Novel Antibodies
            • Bassil Dahiyat, PhD - President and CEO, Xencor
            1:45pm - 2:15pm30 mins
            Workshop 1: Engineering Considerations for Candidate Selection and Developability
            Networking Refreshment Break
              1:45pm - 2:15pm30 mins
              Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
              Networking Refreshment Break
                2:15pm - 2:45pm30 mins
                Workshop 1: Engineering Considerations for Candidate Selection and Developability
                Mitigation of Biopharmaceuticals Immunogenicity During Drug Design
                • Sophie Tourdot - Immunogenicity Sciences Lead, Pfizer
                2:15pm - 2:45pm30 mins
                Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
                Unlocking Value: Navigating the Patent Maze for Antibody Therapeutics
                • Gargi Talukder, PhD - Partner, Orrick
                2:45pm - 3:15pm30 mins
                Workshop 1: Engineering Considerations for Candidate Selection and Developability
                Predicting Antibody Developability Using Interpretable Machine Learning
                • Peter Tessier, PhD - Albert M. Mattocks Professor, Departments of Pharmaceutical Sciences, Chemical Engineering and Biomedical Engineering, University of Michigan
                2:45pm - 3:15pm30 mins
                Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
                The China Biotech Boom
                • Pamela Holland, PhD - Senior Vice President, Biology, InduPro
                3:15pm - 3:45pm30 mins
                Workshop 1: Engineering Considerations for Candidate Selection and Developability
                Machine Learning-driven Design of Next Generation Antibodies with Enhanced Functionality
                • Noelle Huskey Mullin, PhD - Director, Discovery Medicine, BigHat Biosciences
                3:15pm - 3:45pm30 mins
                Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
                Panel Discussion
                • Jonathan Sockolosky, PhD - Principal, Sockolosky & Associates
                • Jennifer Cochran, Ph.D. - Professor and Department Chair of Bioengineering, Stanford University
                3:45pm - 4:00pm15 mins
                Workshop 1: Engineering Considerations for Candidate Selection and Developability
                Concluding Remarks
                  3:45pm - 4:00pm15 mins
                  Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
                  Concluding Remarks

                    * 不測の事態により、事前の予告なしにプログラムが変更される場合があります。

                    Next Main Conference Day 1